Skip to main content
. 2022 Feb 14;36(3):301–313. doi: 10.1007/s40263-021-00890-1

Table 4.

Summary of adverse events (AEs) (safety set)

HSK3486 (n = 135) Propofol (n = 132) P-value
Any AEs 71 (52.6) 101 (76.5) < 0.001
 Grade 1 (mild) 61 (45.2) 86 (65.2) 0.001
 Grade 2 (moderate) 20 (14.8) 30 (22.7) 0.098
 Grade 3 (severe) 0 (0.0) 4 (3.0) 0.125
Drug-related AEs 50 (37.0) 93 (70.5) < 0.001
 Grade 1 (mild) 37 (27.4) 74 (56.1) < 0.001
 Grade 2 (moderate) 19 (14.1) 26 (19.7) 0.220
 Grade 3 (severe) 0 (0.0) 4 (3.0) 0.125
Any SAEs 0 (0.0) 0 (0.0)
Sedation-related AEs 40 (29.6) 42 (31.8) 0.698
 Hypoxia 8 (5.9) 3 (2.3) 0.133
 Duration (s) 0.609
  Mean ± SD 180.80 ± 172.93 180.70 ± 103.35
  Median (range) 142.00 (32,555) 122.00 (120, 300)
 Hypotension 28 (20.7) 36 (27.3) 0.211
 Duration (s) 0.520
  Mean ± SD 462.80 ± 379.78 646.30 ± 830.31
  Median (range) 390.00 (120, 1620) 360.00 (120, 4800)
 Bradycardia 8 (5.9) 9 (6.8) 0.765
 Duration (s) 0.656
  Mean ± SD 687.00 ± 540.84 591.80 ± 304.93
  Median (range) 566.00 (143, 1560) 567.00 (124, 1080)
AEs related to operant reactions to fiberoptic bronchoscopy 3 (2.2) 4 (3.0) 0.976

Data are given as numbers with percentages in parentheses

SAEs serious AEs, SD standard deviation